BTIG analyst Thomas Shrader raised the price target on Verona Pharma (NASDAQ: VRNA) to $77.00 (from $51.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE